4D Molecular Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of FDMT for the last quarter is 3.00 k USD, and it's 40.00% lower compared to the previous quarter. The net income of Q3 24 is -43.84 M USD.